Chinese Journal of Pharmacology: English Edition , 2002, 23(5): 412-422 4
In Stock BPC-157 + GHK-GHK-Cu + TB-500 50MG is a 50-milligram combination format bringing together three widely studied research peptides used in preclinical recovery and tissue-model work
Copper peptides work alongside skin-supportive ingredients to encourage collagen support, improve skin tone, and strengthen the barrier
The Denmark-based company announced Wednesday it had received a Complete Response Letter for dasiglucagon, which it was proposing for the ultra-rare genetic disease congenital hyperinsulinism, due to the timing of a third-party manufacturing facility reinspection. In an initial visit, the FDA had flagged deficiencies in a third-party contract manufacturer, which the company claims had been resolved by the time of a reinspection in August/September 2024
TB-500 (the fragment) has a substantial preclinical evidence base, though it's somewhat smaller than BPC-157's